Study guide
21.1 Surgical Anatomy, Local Anaesthesia & Excision Principles
UEMS European Board of Dermatovenereology Diploma Examination Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Structure, Eligibility & Examination Regulations
1.1 EBDVD Exam Format, Session Timing & Scoring Rules 1.2 Eligibility Routes, Application Requirements & Re-take Regulations 1.3 UEMS-EBDV Governance, European Training Requirements & Diploma Recognition
2 Chapter 2: Dermatologic Terminology, Lesion Morphology & Skin Biology
2.1 Skin Anatomy, Epidermal Biology & Barrier Function 2.2 Primary & Secondary Lesion Morphology 2.3 Cutaneous Immunology & Pathophysiological Reaction Patterns
3 Chapter 3: Dermatopathology & Diagnostic Procedures
3.1 Biopsy Selection, Processing & Special Staining Techniques 3.2 Major Histopathologic Patterns & Tissue Reaction Types 3.3 Direct & Indirect Immunofluorescence Microscopy
4 Chapter 4: Epidemiology, Photobiology & Occupational Dermatology
4.1 Epidemiological Principles & Cutaneous Disease Burden 4.2 Photobiology & Photoprotection 4.3 Occupational Dermatoses & Contact Sensitisation Surveillance
5 Chapter 5: Papulosquamous, Follicular & Adnexal Disease
5.1 Psoriasis: Variants, Psoriatic Arthritis, Comorbidity & European Management 5.2 Lichen Planus, Lichenoid Eruptions & Other Papulosquamous Disorders 5.3 Acne Vulgaris, Rosacea & Perioral Dermatitis 5.4 Hidradenitis Suppurativa, Hyperhidrosis & Other Sweat Gland Disorders
6 Chapter 6: Hair, Nails & Pigmentary Disorders
6.1 Hair Disorders: Non-Scarring & Scarring Alopecia, Hair Shaft Defects & Hirsutism 6.2 Nail Disorders, Onychomycosis & Nail Unit Tumours 6.3 Pigmentary Disorders: Vitiligo, Melasma & Other Hypo- and Hyperpigmentation
7 Chapter 7: Drug Reactions, Granulomatous & Deposition Disease and Skin Signs of Systemic Disease
7.1 Cutaneous Adverse Drug Reactions, SCARs & Dermatological Emergencies 7.2 Granulomatous & Deposition Disorders and Panniculitis 7.3 Skin Signs of Systemic Disease, Porphyrias, Nutritional Deficiency & Paraneoplastic Dermatoses
8 Chapter 8: Pruritus, Pregnancy & Geriatric Dermatology, Physical Injury and Mucosal Disease
8.1 Chronic Pruritus, Chronic Prurigo, Dermatoses of Pregnancy & Geriatric Dermatology 8.2 Burns, Cold, Heat & Radiation Injury and the Principles of Wound Healing 8.3 Oral Mucosal, Lip, Genital Mucosal & Perianal (Proctological) Disease
9 Chapter 9: Autoimmune Bullous Diseases
9.1 Pemphigus Group: Pemphigus Vulgaris, Foliaceus & Paraneoplastic Pemphigus 9.2 Pemphigoid Group & Epidermolysis Bullosa Acquisita 9.3 Dermatitis Herpetiformis & Linear IgA Bullous Dermatosis
10 Chapter 10: Eczematous Disorders, Urticaria & Allergology
10.1 Atopic Dermatitis: Pathogenesis, Phenotypes & European Management 10.2 Allergic & Irritant Contact Dermatitis: Pathogenesis, Investigation & Common Allergens 10.3 Urticaria, Angioedema & Cutaneous Mastocytosis 10.4 Immediate-Type Allergy: Diagnostics, Anaphylaxis, Food, Venom & Drug Allergy
11 Chapter 11: Connective Tissue Diseases & Cutaneous Vasculitis
11.1 Cutaneous Lupus Erythematosus Spectrum & Systemic Manifestations 11.2 Dermatomyositis, Systemic Sclerosis & Scleroderma Spectrum 11.3 Cutaneous Vasculitis & Neutrophilic Dermatoses
12 Chapter 12: Paediatric & Genetic Dermatology
12.1 Vascular Anomalies & Benign Neonatal Dermatoses 12.2 Hereditary Ichthyoses & Disorders of Keratinisation 12.3 Genodermatoses, Neurocutaneous Syndromes & Epidermolysis Bullosa
13 Chapter 13: Bacterial, Mycobacterial, Parasitic & Zoonotic Cutaneous Infections
13.1 Bacterial Skin & Soft Tissue Infections 13.2 Mycobacterial Infections: Cutaneous Tuberculosis, Leprosy & Atypical Mycobacteria 13.3 Parasitic Infestations, Arthropod Bites & Cutaneous Leishmaniasis 13.4 Lyme Borreliosis, Rickettsioses & Other Zoonotic and Travel-Related Skin Infections
14 Chapter 14: Viral & Fungal Cutaneous Infections
14.1 Herpesviridae Infections: HSV, VZV & HHV-8 14.2 Poxviruses & Human Papillomavirus Manifestations 14.3 Superficial, Subcutaneous & Deep Mycoses
15 Chapter 15: Sexually Transmitted Infections & Genital Infections
15.1 Syphilis: Pathogenesis, Clinical Stages, Serology & European Management 15.2 Neisseria gonorrhoeae, Chlamydia trachomatis & Genital Ulcer Diseases 15.3 HIV-Related Dermatoses, Partner Notification & Anogenital Lichen Sclerosus 15.4 Non-Gonococcal Urethritis, Mycoplasma genitalium, Trichomoniasis, Vaginal Infections & Balanitis
16 Chapter 16: Sexual Health Services, HIV Prevention & Anogenital Medicine
16.1 STI Epidemiology, Prevention, Services, Sexual History, HIV Testing, ART & PrEP/PEP 16.2 HPV-Related Anogenital Neoplasia, Cervical Screening & Common Gynaecological and Andrological Disorders 16.3 STIs in Pregnancy, Neonates & Children, Contraception, Sexual Health & Psychosexual Problems
17 Chapter 17: Keratinocyte Carcinomas, Precancerous Lesions & Other Skin Tumours
17.1 Actinic Keratoses, Bowen Disease & Field Cancerisation 17.2 Basal Cell Carcinoma: Subtypes, Risk Stratification & Management 17.3 Cutaneous Squamous Cell Carcinoma & Keratoacanthoma 17.4 Benign & Malignant Epidermal, Adnexal, Mesenchymal and Vascular Tumours, Cysts, Histiocytoses & Metastases
18 Chapter 18: Melanocytic Naevi & Melanoma
18.1 Benign Melanocytic Naevi: Acquired, Congenital, Spitz, Blue, Halo & Atypical Naevi 18.2 Melanoma Risk Factors, Clinical Presentation & Biopsy Protocol 18.3 Melanoma Histopathology, Breslow Thickness & Staging 18.4 Systemic Therapy for Advanced & Metastatic Melanoma
19 Chapter 19: Dermoscopy, Skin Imaging & Cutaneous Lymphomas
19.1 Dermoscopic Principles, Structures & Algorithmic Approaches 19.2 Dermoscopy of Non-Melanocytic Cutaneous Neoplasms 19.3 Non-Invasive Skin Imaging, Skin Function Measurement, Teledermatology & Skin Cancer Surveillance 19.4 Cutaneous Lymphomas, Merkel Cell Carcinoma & Cutaneous Sarcomas
20 Chapter 20: Dermatopharmacology, Systemic Therapeutics & Prescribing
20.1 Topical Corticosteroids, Calcineurin Inhibitors & Retinoids 20.2 Systemic Immunosuppressive & Biologic Therapies 20.3 Oral Retinoids & Phototherapy Modalities 20.4 Dermatological Prescribing: Anti-Infectives, Antihistamines, Antimalarials, Dapsone, Special Populations & Cutaneous Toxicity of Cancer Therapy
21 Chapter 21: Dermatosurgery, Cryotherapy, Lasers & Aesthetic Procedures
21.1 Surgical Anatomy, Local Anaesthesia & Excision Principles 21.2 Cutaneous Reconstructive Flaps, Skin Grafts & Surgical Complications 21.3 Cryosurgery, Electrosurgery & Cutaneous Lasers 21.4 Aesthetic & Corrective Dermatology, Photodynamic Therapy & Dermatological Radiotherapy
22 Chapter 22: Phlebology, Angiology, Psychodermatology & EBDVD Revision
22.1 Phlebology, Chronic Venous Insufficiency & Lower Extremity Ulcers 22.2 Angiology: Arterial Disease, Raynaud Phenomenon, Livedo, Thrombosis, Lymphoedema & Lipoedema 22.3 Psychodermatology, Delusional Infestation & Factitious Disorders 22.4 EBDVD Revision Strategy & Cross-Topic Review
21.1 Surgical Anatomy, Local Anaesthesia & Excision Principles
Key Takeaways Explain This Topic AI
Relaxed Skin Tension Lines (RSTLs) follow natural cutaneous furrows oriented perpendicular to underlying dynamic mimetic muscular contractions; orienting incisions parallel to RSTLs minimizes mechanical wound distraction, accelerates healing, and conceals surgical scars within natural rhytides.
Facial nerve branches (cranial nerve VII) are exceptionally vulnerable in danger zones where they course superficially: the temporal branch traverses the zygomatic arch within the temporoparietal fascia (injury causes brow ptosis and frontalis paralysis), while the marginal mandibular branch crosses the inferior mandibular border superficial to facial vessels (injury causes lower lip depressor paralysis and an asymmetric smile).
The spinal accessory nerve (cranial nerve XI) emerges at Erb's point in the posterior cervical triangle under a thin layer of investing fascia; iatrogenic transection produces trapezius paralysis, lateral scapular winging, and inability to abduct the arm past 90 degrees.
Plain 1% lidocaine has a maximum safe dosage threshold of 4.5 mg/kg (up to ~300 mg in an adult), whereas 1% lidocaine with adrenaline (1:100,000–1:200,000) raises the ceiling to 7.0 mg/kg (up to ~500 mg) through intense alpha-1 vasoconstriction that delays systemic absorption and prolongs anaesthetic duration.
Buffering acidic commercial lidocaine with adrenaline using 8.4% sodium bicarbonate in a 1:9 to 1:10 volume ratio elevates pH to physiological levels (7.2–7.4), shifting local anaesthetic molecules into the uncharged lipophilic base to expedite membrane penetration and abolish infiltration pain.
Last updated: September 2026
- 21.1 Surgical Anatomy, Local Anaesthesia & Excision Principles
- Cutaneous Surgical Anatomy & Biomechanics
Excellence in dermatological surgery demands an exhaustive understanding of skin biomechanics, structural topographical anatomy, and the three-dimensional architecture of the face. An incision executed without regard to relaxed skin tension lines or aesthetic subunit boundaries results in unsightly, widened, hypertrophic scars and permanent functional impairment of dynamic facial structures.
Relaxed Skin Tension Lines (RSTLs) vs. Langer Lines
For over a century, surgical trainees were taught to rely on Langer lines , originally described by Austrian anatomist Karl Langer in 1861. Langer mapped static cleavage lines by puncturing circular holes into the skin of stiffened cadavers and recording the resulting elliptical fissures caused by intrinsic collagen bundle tension. However, Langer lines fail to reflect the dynamic, living, mobile reality of human skin.
In 1962, Alfred Borges introduced the concept of Relaxed Skin Tension Lines (RSTLs) , which represent the true gold standard for surgical planning in living patients:
Biomechanical Definition: RSTLs represent the natural orientation of skin tension at rest. They run strictly perpendicular to the direction of underlying dynamic muscular contractions of the facial mimetic musculature.
Dynamic Significance: When an incision is aligned precisely parallel to or within an RSTL, the distracting lateral vector forces produced by mimetic muscle contractions are neutralized. Instead of pulling the wound edges apart, the muscles compress or stabilize the incision, yielding minimal closure tension, rapid primary re-epithelialization, and cosmetically superior linear scars hidden within natural skin furrows.
Clinical Determination: RSTLs are visualized by asking the patient to animate their face (e.g., scowling, smiling, raising eyebrows, wrinkling the nose). In resting or elder skin, gentle manual compression ( the pinch test ) perpendicular to relaxed creases easily reveals the orientation of greatest cutaneous laxity and parallel skin folding.
Kraissl Lines: Closely mirror RSTLs on the face and follow the static creases produced by repeated joint and muscular flexion. Dynamic Muscle Contraction ──> [ Direction of Vector Force ]
- │
- (Perpendicular 90°)
- ▼
- Relaxed Skin Tension Line (RSTL) ──> [ Optimal Surgical Incision Line ]
- Facial Aesthetic Units & Free Margins
Introduced by Burget and Menick, the Aesthetic Subunit Principle states that the human face is visually perceived not as a uniform sheet of skin, but as an assembly of distinct, three-dimensional topographic regions separated by natural shadows, light reflections, and contour borders.
The Major Aesthetic Units and Subunits
Forehead: Divided into central forehead, paired lateral temples, and paired eyebrow units.
Periorbital: Upper and lower eyelids, medial and lateral canthi.
Nose (Highly Complex Topography):
Convex subunits: Tip, paired alar lobules, and columella.
Flat/concave subunits: Dorsum and paired lateral nasal sidewalls.
Cheeks: Medial cheek (infraorbital), lateral cheek (preauricular), and zygomatic/malar cheek.
Lips: Upper lip (subdivided into central philtrum and paired lateral lip elements) and lower lip.
Chin: Mental unit, bordered superiorly by the mental crease.
The 50% Subunit Reconstruction Rule
When an oncological defect (e.g., following Mohs micrographic surgery or wide local excision) encompasses greater than 50% of the surface area of a convex aesthetic subunit (such as the nasal tip or alar lobule), attempting to reconstruct only the defect often produces an unnatural, visible patch bordered by haphazard scars. Superior aesthetic outcomes are achieved by deliberately excising the remaining undamaged skin of that entire subunit and reconstructing the entire anatomical subunit as a single aesthetic entity. Scars placed along the natural junctional boundaries between aesthetic units (such as the melolabial fold, nasofacial groove, alar crease, or vermilion border) are virtually invisible to visual inspection.
Preservation of Facial Free Margins
A free margin is an anatomical edge that lacks rigid, deep skeletal fixation. The primary facial free margins include:
- Lower and upper eyelid margins
- Alar rims of the nostrils
- Vermilion border of the lips
- Earlobe and helix rim
Examination Pearl: Any surgical closure that exerts mechanical tension perpendicular to a facial free margin will inevitably cause catastrophic functional and cosmetic deformities: ectropion (lower eyelid retraction with secondary epiphora and exposure keratopathy), alar notching/retraction (external nasal valve collapse with airway obstruction), or vermilion notch / step-off (oral incompetence). In dermatological surgery, wound closure tension vectors must always be oriented parallel to free margins , never perpendicular.
Facial Surgical Danger Zones
Iatrogenic nerve transection represents one of the most litigated and devastating complications in cutaneous surgery. Dermatologists operating on the head and neck must master the four primary neurovascular danger zones where major motor and sensory nerves travel in a superficial, vulnerable tissue plane. TEMPORAL DANGER ZONE
- (Pitanguy's line: Tragus to
- 1.5 cm above lateral eyebrow)
- │
- ▼
- [Temporal Branch of CN VII]
- Traverses zygomatic arch within
- temporoparietal fascia (TPF)
- Paralysis: Unilateral brow ptosis
- │
- ▼
- ┌─────────────────────────────────────────┐
- │ │
- ▼ ▼
- MARGINAL MANDIBULAR ZONE POSTERIOR TRIANGLE DANGER ZONE
- (Anterior border of masseter at (Erb's point: posterior border
- inferior mandibular margin) of sternocleidomastoid)
- │ │
- ▼ ▼
- [Marginal Mandibular Branch of VII] [Spinal Accessory Nerve / CN XI]
- Superficial to facial artery/vein Beneath thin investing fascia
- Paralysis: Lower lip depression failure Paralysis: Trapezius winging,
- Asymmetric smile & oral drooling loss of arm abduction >90°
- 1. Temporal (Frontal) Branch of the Facial Nerve (CN VII)
Anatomical Course (Pitanguy's Line): Pitanguy's line is drawn from a point 0.5 cm inferior to the tragus of the ear to a point 1.5 cm superior and lateral to the lateral tail of the eyebrow. The temporal branch emerges from the superior aspect of the parotid gland and crosses the middle third of the zygomatic arch on its superior journey into the forehead.
Vulnerable Tissue Plane: As it crosses the zygomatic arch, the nerve transitions from a deep plane into a dangerously superficial plane, running within or immediately beneath the temporoparietal fascia (TPF / superficial temporal fascia) , directly overlying the deep temporal fascia.
Motor Innervation: Innervates the frontalis muscle, superior portion of orbicularis oculi, and corrugator supercilii.
Clinical Deficit: Transection produces complete unilateral paralysis of the frontalis muscle, resulting in unilateral brow ptosis , loss of transverse forehead rhytides on animation, asymmetry of the upper face, and secondary visual field obstruction from descending brow tissue.
Surgical Safety Guideline: Dissection in the temple must remain either strictly superficial in the upper subcutaneous fat (above the TPF) or strictly sub-galeal / sub-periosteal directly on the calvarium.
2. Marginal Mandibular Branch of the Facial Nerve (CN VII)
Anatomical Course: Emerges from the inferior pole of the parotid gland, passes over or up to 1–2 cm below the inferior margin of the mandible, and crosses the mandibular border anterior to the masseter muscle.
Vulnerable Tissue Plane: As it crosses the mandible, the nerve lies directly superficial to the facial artery and anterior facial vein , covered only by the thin platysma muscle , superficial cervical fascia, subcutaneous fat, and skin.
Motor Innervation: Depressor anguli oris, depressor labii inferioris, and mentalis.
Clinical Deficit: Iatrogenic injury paralyzes lower lip depression on the ipsilateral side. When the patient smiles or grimaces, the normal contralateral lower lip depresses downward, while the paralyzed ipsilateral lip remains elevated, resulting in an obvious asymmetrical, crooked smile , lower lip incompetence, drooling, and frequent accidental biting of the lower lip.
Surgical Safety Guideline: Any surgical undermining over the mandibular margin anterior to the masseter must stay in the mid-to-superficial subcutaneous fat, well superficial to the platysma.
3. Spinal Accessory Nerve (Cranial Nerve XI) & Erb's Point
Anatomical Course: Cranial nerve XI emerges from the posterior border of the sternocleidomastoid (SCM) muscle at Erb's point (punctum nervosum) , located approximately at the junction of the upper and middle thirds of the posterior border of the SCM (approximately 6 cm inferior to the mastoid tip). It traverses the posterior triangle of the neck obliquely downward and backward to enter the anterior border of the trapezius muscle.
Vulnerable Tissue Plane: In the posterior cervical triangle, the nerve is remarkably superficial, resting directly on the levator scapulae muscle beneath only the skin, subcutaneous fat, and the thin investing layer of deep cervical fascia.
Motor Innervation: Sternocleidomastoid and trapezius muscles.
Clinical Deficit: Transection leads to trapezius muscle atrophy and paralysis , causing painful drooping of the shoulder girdle, lateral winging of the scapula (the inferior angle rotates laterally and downward, in contrast to medial winging caused by long thoracic nerve injury to the serratus anterior), and inability to abduct the arm above 90 degrees due to loss of scapular upward rotation.
Surgical Safety Guideline: Excision of lipomas, epidermoid cysts, or lymph nodes in the posterior cervical triangle must avoid deep dissection through the investing cervical fascia without formal nerve identification.
4. Great Auricular Nerve & Key Sensory Branches
Great Auricular Nerve (C2–C3): Emerges at Erb's point and ascends vertically across the superficial surface of the SCM towards the earlobe. Transection causes permanent numbness of the lower two-thirds of the pinna, earlobe, and preauricular skin.
Trigeminal Nerve Sensory Branches (CN V):
Supraorbital and Supratrochlear nerves (V1): Emerge from the superior orbital rim/notch; injury causes forehead and anterior scalp numbness.
Infraorbital nerve (V2): Exits the infraorbital foramen (approx. 1 cm inferior to the infraorbital rim on the mid-pupillary line); transection causes ipsilateral numbness of the lower eyelid, lateral nose, and upper lip.
Mental nerve (V3): Exits the mental foramen beneath the mandibular second premolar; transection causes complete anesthesia of the ipsilateral lower lip and chin.
Summary Table: Facial Neurovascular Danger Zones
Danger Zone & Target Nerve Anatomical Landmarks & Course Vulnerable Tissue Plane Clinical Deficit Following Iatrogenic Injury Safe Surgical Dissection Plane
Temporal (Frontal) Branch (CN VII) Pitanguy's line: 0.5 cm below tragus to 1.5 cm above lateral eyebrow; crosses middle third of zygomatic arch. Within or deep to temporoparietal fascia (TPF); resting on deep temporal fascia. Frontalis paralysis; unilateral brow ptosis; loss of forehead rhytides; visual field cut. Superficial subcutaneous fat above TPF, or deep sub-periosteal plane.
Marginal Mandibular Branch (CN VII) Inferior border of mandible anterior to masseter muscle; 1–2 cm below mandibular angle. Directly superficial to facial artery/vein; beneath or within platysma muscle. Depressor labii inferioris paralysis; asymmetric crooked smile; drooling; lower lip bite. Superficial subcutaneous fat, strictly superficial to platysma.
Spinal Accessory Nerve (CN XI) Erb's point: junction of upper/middle third of posterior border of SCM; traverses posterior triangle. Superficial beneath skin, fat, and thin investing layer of deep cervical fascia. Trapezius paralysis; shoulder drop; lateral scapular winging; inability to abduct arm >90°. Superficial to investing cervical fascia; avoid blind clamping in posterior triangle.
Great Auricular Nerve (C2–C3) Emerges at Erb's point, ascends vertically over middle third of SCM towards lobule. Immediately beneath subcutaneous fat on the external surface of SCM. Permanent sensory loss/anaesthesia of earlobe, lower pinna, and preauricular skin. Superficial subcutaneous plane; avoid deep transection across mid-SCM.
Mental Nerve (CN V3) Mental foramen: inferior to second mandibular premolar, midway between alveolar crest and base. Emerges from deep bony foramen directly into lower lip submucosa/subcutis. Permanent numbness and paresthesia of lower lip and chin; oral incompetence. Submucosal or mid-subcutaneous plane; avoid aggressive periosteal scraping.
Pharmacology of Local Anaesthesia
Local anaesthetics (LAs) are the pharmacological workhorses of cutaneous surgery. Understanding their chemical structures, electrophysiological mechanisms, toxicity profiles, and formulation kinetics is essential for patient safety and procedural efficacy.
Molecular Structure & Sodium Channel Electrophysiology
Local anaesthetic molecules share a three-part chemical anatomy:
Lipophilic Aromatic Ring: Determines lipid solubility, periaxonal tissue penetration, and intrinsic anaesthetic potency.
Intermediate Hydrocarbon Chain: Determines whether the drug belongs to the ester or amide class.
Hydrophilic Tertiary Amine: Determines water solubility, ionization state, and binding kinetics at the receptor.
Mechanism of Action
At physiological pH, local anaesthetics exist in equilibrium between an uncharged, non-ionized lipophilic base (B) and a charged, protonated cationic conjugate (BH+):
B + H+ <===> BH+
The non-ionized base (B) is lipophilic and diffuses across the hydrophobic neuronal epineurium and lipid bilayer of the axonal membrane. Once inside the relatively neutral axoplasm, the molecule rapidly protonates back into the active cationic form (BH+). The charged cation binds with high affinity to the intracellular S6 segment of domain IV of the voltage-gated sodium channel (Nav1) , locking the channel in an inactivated state. This physically occludes the channel pore, prevents inward sodium influx, abolishes axonal depolarization, and halts saltatory action potential propagation.
Differential Nerve Susceptibility
Nerve fibers exhibit differential sensitivity to local blockade based on fiber diameter and myelination status:
Small unmyelinated C-fibers (transmitting dull, aching pain and warmth) and small myelinated A-delta fibers (transmitting sharp pain and cold temperature) are blocked first .
Large myelinated A-beta fibers (touch, pressure, vibration) are blocked second .
Large myelinated A-alpha motor fibers (motor function and proprioception) are blocked last .
Clinical Pearl: Patients under local anaesthesia frequently perceive mechanical pressure, pulling, and vibration (carried by resistant A-beta fibers) while remaining completely insensate to sharp surgical cutting (carried by blocked A-delta and C fibers). Reassuring the patient in advance prevents unnecessary re-injection.
- Amide vs. Ester Local Anaesthetics
- Amides
Chemical Linkage: Contain an amide bond (-NH-CO-) in the intermediate chain.
Nomenclature Mnemonic: All amides contain two letter 'i's in their name (e.g., L-i-doca-i-ne, Bup-i-vaca-i-ne, Mep-i-vaca-i-ne, Rop-i-vaca-i-ne, Pr-i-loca-i-ne).
Metabolism: Metabolized in the liver via microsomal cytochrome P450 enzymes (predominantly CYP3A4 and CYP1A2). Hepatic clearance is significantly reduced in cirrhosis, severe congestive heart failure, and during concurrent therapy with CYP3A4 inhibitors (e.g., ketoconazole, erythromycin).
Allergy Profile: True IgE-mediated type I allergy to amides is exceptionally rare (<1% of all adverse local anaesthetic events). Cross-reactivity between different amide agents is virtually absent.
Esters
Chemical Linkage: Contain an ester bond (-COO-) in the intermediate chain.
Nomenclature Mnemonic: Esters contain only one letter 'i' in their name (e.g., Proca-i-ne, Tetraca-i-ne, Chloroproca-i-ne, Coca-i-ne, Benzoca-i-ne).
Metabolism: Rapidly hydrolyzed in the plasma by pseudocholinesterase (butyrylcholinesterase) into para-aminobenzoic acid (PABA) .
Allergy Profile: Esters carry a substantially higher risk of allergic hypersensitivity. The PABA metabolite is a potent sensitizer. Patients allergic to one ester will cross-react with all other esters and other PABA-containing agents (such as older sunscreen filters, sulfonamides, and thiazide diuretics).
The Multi-Dose Paraben Trap: Many commercial multi-dose vials of amide anaesthetics contain methylparaben as an antibacterial preservative. Methylparaben is structurally homologous to PABA and can induce contact allergy or acute bronchospasm. When an amide allergy is suspected, testing must be performed using preservative-free single-dose ampoules .
Lidocaine Pharmacology & Adrenaline Interactions
Lidocaine (lignocaine) remains the premier local anaesthetic agent in cutaneous surgery due to its rapid onset, wide safety margin, and low tissue toxicity.
Maximum Safe Dosage Thresholds
Plain 1% Lidocaine: 4.5 mg/kg (maximum absolute ceiling: 300 mg , equivalent to 30 mL of a 1% solution in a 70 kg adult).
1% Lidocaine with Adrenaline (Epinephrine 1:100,000 or 1:200,000): 7.0 mg/kg (maximum absolute ceiling: 500 mg , equivalent to 50 mL of a 1% solution in a 70 kg adult).
Physiological Benefits of Adrenaline Co-Administration
Intense Vasoconstriction: Acts on vascular smooth muscle alpha-1 adrenergic receptors, clamping microcirculatory flow to create an almost completely bloodless operative field.
Prolonged Anaesthetic Duration: Minimizes local vascular washout, prolonging clinical duration of action from 30–60 minutes (plain) to 120–360 minutes .
Reduced Peak Systemic Absorption: Slower vascular uptake flattens the systemic plasma concentration curve, reducing peak serum levels by 30%–50% and expanding the safe therapeutic window.
Enhanced Tissue Visualization: Blanching clearly outlines the infiltrated area and improves surgical precision.
The Demise of the Digital Adrenaline Myth (WALANT)
For decades, medical textbooks warned that adrenaline co-injection into end-arterial acral anatomical sites (fingers, toes, penis, nose, ears) was strictly contraindicated due to the risk of irreversible ischemic necrosis. Modern evidence encompassing over 500,000 documented cases (the WALANT protocol: Wide-Awake Local Anesthesia No Tourniquet) has conclusively disproven this dogma. Adrenaline in 1:100,000 to 1:200,000 dilutions is completely safe in acral surgery. If prolonged, refractory vasospasm ever occurs, it can be immediately reversed with local infiltration of the competitive alpha-adrenergic blocker phentolamine (1–2 mg in 1–5 mL of normal saline).
Local Anaesthetic Systemic Toxicity (LAST)
Systemic toxicity occurs from inadvertent intravascular injection or massive overdose, resulting in toxic plasma concentrations that cross the blood-brain barrier and poison cardiac conduction.
Clinical Progression of LAST
Early CNS Excitation: Circumoral numbness, metallic taste in the mouth, tongue paresthesias, tinnitus, lightheadedness, apprehension, visual disturbances, slurred speech, fine muscle twitching, and resting tremors.
Severe CNS Toxicity: Generalized tonic-clonic convulsions, progressive CNS depression, stupor, loss of consciousness, and respiratory arrest.
Cardiovascular Collapse: Severe myocardial depression, conduction block, prolonged PR and QRS intervals, refractory ventricular arrhythmias (ventricular tachycardia, torsades de pointes, ventricular fibrillation), and electromechanical dissociation / asystole. Bupivacaine is notoriously cardiotoxic due to its slow dissociation from cardiac sodium channels.
Emergency Management Protocol
Halt injection immediately and summon emergency resuscitation assistance.
Airway & Oxygenation: Administer 100% oxygen; perform early tracheal intubation if airway control is compromised. Hypoxia and acidosis dramatically worsen local anaesthetic toxicity.
Seizure Management: Administer IV benzodiazepines (midazolam 1–2 mg IV or diazepam). Avoid propofol in hemodynamically compromised patients.
Lipid Emulsion Therapy (20% Intralipid): The definitive pharmacological antidote.
Bolus: Administer 1.5 mL/kg of 20% lipid emulsion over 1 minute (~100 mL in a 70 kg adult).
Infusion: Immediately begin continuous IV infusion at 0.25 mL/kg/min .
Refractory Instability: Repeat the bolus up to two times at 5-minute intervals and increase the infusion rate to 0.5 mL/kg/min (maximum cumulative dose: 10–12 mL/kg over the first 30 minutes).
Mechanism: Acts as a lipid sink (extracts lipophilic local anaesthetic molecules from myocardial tissue into intravascular lipid droplets) and restores mitochondrial fatty acid beta-oxidation.
Buffering Dynamics: Neutralizing Acidity with Sodium Bicarbonate
Commercial solutions of lidocaine containing adrenaline are formulated at an acidic pH ( pH 3.5 to 4.5 ) to prevent the oxidation of adrenaline, which degrades rapidly in neutral or alkaline solutions. This acidic pH causes sharp, stinging, burning pain upon subcutaneous infiltration.
Buffering Protocol: Add 1 mL of 8.4% Sodium Bicarbonate to 9 mL or 10 mL of 1% lidocaine with adrenaline (a 1:9 or 1:10 volume ratio).
Biochemical Mechanism: Adding bicarbonate shifts the solution pH to physiological 7.2 to 7.4 . According to the Henderson-Hasselbalch principle, this dramatic pH rise shifts the chemical equilibrium toward the non-ionized, lipophilic free base (B). The uncharged base diffuses across nerve sheaths and cell membranes exponentially faster, slashing anaesthetic onset latency to under 30 seconds while abolishing injection pain.
Storage Caution: Buffered lidocaine with adrenaline must be utilized within 24 hours , as adrenaline progressively degrades at neutral pH.
Tumescent Local Anaesthesia: The Klein Protocol
Pioneered by Jeffrey Klein in 1987, tumescent local anaesthesia permits extensive cutaneous surgical procedures to be performed without general anaesthesia or intravenous sedation.
The Klein Formulation
Into 1000 mL of 0.9% normal saline, the following agents are added:
- Lidocaine: 500 mg to 1000 mg (resulting in a dilute 0.05% to 0.1% concentration)
- Adrenaline (Epinephrine): 1 mg (1:1,000,000 dilution)
- Sodium Bicarbonate 8.4%: 10 to 12.5 mEq (10–12.5 mL)
- Pharmacokinetics & Exceptional Safety Margin
When large volumes of this dilute solution are infiltrated into subcutaneous fat, tissue turgor (tumescence) produces hydraulic tissue plane dissection and profound microvascular vasoconstriction. Because subcutaneous adipose is relatively avascular and adrenaline shuts down local perfusion, the systemic absorption of lidocaine is extraordinarily delayed. Peak serum concentrations are not reached until 12 to 14 hours post-infiltration .
Consequently, the maximum safe dosage of lidocaine under the tumescent technique expands to 35 mg/kg to 55 mg/kg (compared to 7 mg/kg for standard infiltration). Indications include large-volume liposuction, ambulatory phlebectomy, hair transplantation, extensive burn excision, and reconstruction of massive Mohs surgical defects.
Summary Table: Local Anaesthetic Agents in Dermatological Surgery
Local Anaesthetic Class Onset of Action Duration (Plain) Duration (+ Adrenaline) Max Dose Plain (mg/kg) Max Absolute Plain (mg) Max Dose + Adr (mg/kg) Max Absolute + Adr (mg) Key Clinical Characteristics
Lidocaine Amide Rapid (1–2 min) 30–60 min 120–360 min 4.5 300 7.0 500 Workhorse of dermatological surgery; low allergenicity; safe in pregnancy (Category B).
Bupivacaine Amide Slow (5–10 min) 120–240 min 240–480 min 2.0 150 2.5 200 Longest duration; high lipid solubility; highly cardiotoxic; contraindicated in rapid bolus.
Mepivacaine Amide Rapid (2–3 min) 60–90 min 120–180 min 4.5 300 7.0 500 Mild intrinsic vasoconstrictor; useful when adrenaline is medically contraindicated.
Ropivacaine Amide Moderate (3–5 min) 120–180 min 180–360 min 3.0 200 3.5 250 Pure S-enantiomer; similar duration to bupivacaine but significantly less cardiotoxic.
Prilocaine Amide Rapid (2–4 min) 30–60 min 120–240 min 6.0 400 8.0 600 Metabolite (o-toluidine) oxidizes hemoglobin, causing methemoglobinemia (tx: methylene blue).
Procaine Ester Slow (5–10 min) 20–30 min 45–60 min 7.0 500 10.0 600 Hydrolyzed to PABA; high allergenicity; low potency; historically used.
Tetracaine Ester Very slow (10–15 min) 90–120 min 180–240 min 1.5 100 2.0 150 High potency and toxicity; primarily utilized in topical anaesthetic formulations (e.g., LET).
- Surgical Geometry & Layered Closure Techniques
- Elliptical Excision Design
The standard fusiform (elliptical) excision is the quintessential geometric design in dermatological surgery. Its purpose is to completely excise a focal cutaneous lesion while leaving a linear defect that can be re-approximated without tissue puckering.
Length-to-Width Ratio: The optimal length-to-width ratio is 3:1 to 4:1 .
Apical Angles: The apex at each pole must form an angle of 30 degrees or less .
Biomechanical Principle: When an ellipse has a length-to-width ratio <3:1 or apical angles >30 degrees, the circumference of the wound margins exceeds the linear length of the closure line. Upon suturing, redundant skin bunches up at the apices, generating prominent cutaneous conical elevations termed standing cones ('dog ears').
Correction of Standing Cones ('Dog Ears')
If a standing cone arises intraoperatively, several geometric maneuvers achieve primary correction:
Extension of the Ellipse: The simplest approach; extend the incision along the RSTL, lengthening the apex until the angle is <=30 degrees.
Burow's Triangle Excision: A small triangle of redundant skin is excised adjacent to the apex, allowing the redundant margin to advance flatly.
Hockey-Stick (L-plasty) Modification: The apex incision is curved laterally along an adjacent cosmetic crease or RSTL, redirecting the scar line away from vital structures.
M-Plasty: When an ellipse cannot be extended due to proximity to a free margin (e.g., vermilion border, eyelid) or cosmetic boundary, an M-shaped double-apex is incised. The M-plasty creates two smaller 30-degree angles, shortening total scar length by up to 30% while flattening the standing cone.
S-Plasty: Utilized on curved, convex anatomical surfaces (e.g., lower leg, forearm) to break up straight-line scar contracture.
Surgical Undermining Planes
Undermining frees the surrounding skin from deep fascial attachments, mobilizing tissue margins and redistributing closing tension away from the epidermal edge.
Trunk and Extremities: Undermining is performed in the subdermal / upper subcutaneous adipose plane , superficial to the deep muscular fascia. Dissection must maintain a uniform depth to prevent vascular injury.
Scalp: Undermining must be executed in the avascular sub-galeal loose areolar tissue plane (between the galea aponeurotica and the periosteum/pericranium). This plane allows rapid, bloodless mobilization of large scalp flaps.
Face: Dissection must remain strictly in the superficial subcutaneous fat superficial to the SMAS , protecting the branches of the facial nerve running within or beneath the SMAS layer.
- Suture Materials & Tensile Strength Profiles
- Buried Absorbable Sutures
Buried dermal sutures are the mechanical foundation of layered closure. They bear >90% of wound distraction forces, eliminate dead space, and keep wound edges in intimate apposition during the critical 4 to 6 weeks of early collagen synthesis.
Polyglactin 910 (Vicryl): Braided synthetic copolymer of glycolide and lactide. Retains 75% tensile strength at 2 weeks , 50% at 3 weeks , and 25% at 4 weeks ; complete hydrolytic absorption occurs at 56–70 days. High knot security, moderate tissue reactivity.
Poliglecaprone 25 (Monocryl): Monofilament copolymer of glycolide and epsilon-caprolactone. Retains 50%–60% tensile strength at 1 week , 20%–30% at 2 weeks ; complete absorption by 90–120 days. Produces the lowest tissue reactivity among absorbables and glides smoothly through tissue. Ideal for cosmetic facial closures in low-tension sites.
Polydioxanone (PDS II): Monofilament polymer. Retains 70% strength at 2 weeks , 50% at 4 weeks , and 25% at 6 weeks ; complete absorption takes 180–210 days. Ideal for high-tension trunk, back, and joint wounds requiring prolonged mechanical support.
Non-Absorbable Epidermal Sutures
Polypropylene (Prolene): Synthetic monofilament. Exceptional tensile strength, low tissue drag, minimal tissue reactivity, and high plasticity. Best material for continuous running subcuticular sutures and external closure on delicate sites.
Polyamide / Nylon (Ethilon): Synthetic monofilament. Low tissue reactivity, high elasticity, excellent knot security. Standard material for simple interrupted epidermal closure.
Suture Removal Timelines Across Anatomical Sites
Leaving epidermal sutures in place too long allows keratinocytes to migrate downward along the suture tracks, forming permanent, unsightly epithelialized puncture tracks and 'railroad track' cross-hatch scars.
- Face and Eyelids: 5 to 7 days
- Neck: 7 days
- Scalp: 7 to 10 days
- Trunk and Upper Extremities: 10 to 14 days
Lower Extremities, Back, and Joints: 14 to 21 days (delayed due to high distraction forces and slower microvascular healing)
Specialized Suture Techniques
Buried Vertical Dermal Suture: The needle passes deep-to-superficial then superficial-to-deep, placing the knotted loop deep in the adipose layer. This inverts the knot, aligns the reticular dermis, and produces slight wound edge eversion.
Vertical Mattress Suture ('Far-Far, Near-Near'): The far bite (4–8 mm from margin) traverses deep tissue, while the near bite (1–2 mm from margin) traverses superficial papillary dermis. This provides unparalleled wound edge eversion , counteracting the natural cicatricial contracture that tends to pull scars inward into depressed grooves over time.
Horizontal Mattress Suture: Delivers excellent eversion and powerful hemostasis across high-tension wounds or friable, atrophic elderly skin.
Running Subcuticular Closure: Continuous monofilament passes horizontally through the upper reticular dermis; completely eliminates external skin punctures, producing exceptional linear cosmetic scars.